Developing Consistent and Transparent Models of E-cigarette Use: Reply to Glantz and Soneji et al

David T Levy¹, Ron Borland², Geoffrey T Fong^{3

4

5}, Andrea C Villanti⁶, Raymond Niaura⁶, Rafael Meza⁷, Theodore R Holford⁸, K Michael Cummings⁹, David B Abrams^{10

6

11}

Affiliations

¹ Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC; DL777@Geoegretown.edu.
² Nigel Gray Distinguished Fellow in Cancer Prevention, VicHealth Centre for Tobacco Control, Cancer Council Victoria, Melbourne, Australia.
³ Department of Psychology, University of Waterloo, Waterloo, ON, Canada.
⁴ School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada.
⁵ Ontario Institute for Cancer Research, Toronto, ON, Canada.
⁶ Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, Washington, DC.
⁷ Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI.
⁸ Department of Biostatistics, Yale University, New Haven, CT.
⁹ Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
¹⁰ Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
¹¹ Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

PMID: 28082477
PMCID: PMC6296399
DOI: 10.1093/ntr/ntw236

Comment

Developing Consistent and Transparent Models of E-cigarette Use: Reply to Glantz and Soneji et al

David T Levy et al. Nicotine Tob Res. 2017 Feb.

. 2017 Feb;19(2):268-270.

doi: 10.1093/ntr/ntw236. Epub 2016 Oct 6.

Authors

David T Levy¹, Ron Borland², Geoffrey T Fong^{3

4

5}, Andrea C Villanti⁶, Raymond Niaura⁶, Rafael Meza⁷, Theodore R Holford⁸, K Michael Cummings⁹, David B Abrams^{10

6

11}

Affiliations

¹ Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC; DL777@Geoegretown.edu.
² Nigel Gray Distinguished Fellow in Cancer Prevention, VicHealth Centre for Tobacco Control, Cancer Council Victoria, Melbourne, Australia.
³ Department of Psychology, University of Waterloo, Waterloo, ON, Canada.
⁴ School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada.
⁵ Ontario Institute for Cancer Research, Toronto, ON, Canada.
⁶ Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, Washington, DC.
⁷ Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI.
⁸ Department of Biostatistics, Yale University, New Haven, CT.
⁹ Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
¹⁰ Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
¹¹ Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

PMID: 28082477
PMCID: PMC6296399
DOI: 10.1093/ntr/ntw236

Erratum in

Correction to 24 papers to add an additional interest disclosure.
[No authors listed] [No authors listed] Nicotine Tob Res. 2024 Dec 23;27(1):163. doi: 10.1093/ntr/ntae234. Nicotine Tob Res. 2024. PMID: 39405446 Free PMC article. No abstract available.

No abstract available

PubMed Disclaimer

Comment on

Problematic Assessment of the Impact of Vaporized Nicotine Product Initiation in the United States.
Soneji S, Sung HY, Primack B, Pierce JP, Sargent J. Soneji S, et al. Nicotine Tob Res. 2017 Feb;19(2):264-265. doi: 10.1093/ntr/ntw232. Epub 2016 Sep 8. Nicotine Tob Res. 2017. PMID: 27613932 Free PMC article. No abstract available.
The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States.
Levy DT, Borland R, Villanti AC, Niaura R, Yuan Z, Zhang Y, Meza R, Holford TR, Fong GT, Cummings KM, Abrams DB. Levy DT, et al. Nicotine Tob Res. 2017 Feb;19(2):149-159. doi: 10.1093/ntr/ntw158. Epub 2016 Jul 14. Nicotine Tob Res. 2017. PMID: 27613952 Free PMC article.
Need for Examination of Broader Range of Risks When Predicting the Effects of New Tobacco Products.
Glantz SA. Glantz SA. Nicotine Tob Res. 2017 Feb;19(2):266-267. doi: 10.1093/ntr/ntw231. Epub 2016 Oct 6. Nicotine Tob Res. 2017. PMID: 28082476 Free PMC article. No abstract available.

References

1. Levy D, Cummings K, Villanti A, et al. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products [published online ahead of print April 25, 2016]. Addiction. doi:10.1111/add.13394 - PMC - PubMed
1. Levy DT, Borland R, Villanti AC, et al. The application of a decision-theoretic model to estimate the public health impact of vaporized nicotine product initiation in the United States [published online ahead of print July 14, 2016]. Nicotine Tob Res. - PMC - PubMed
1. Glantz S. Need for examination of broader range of risks when predicting the effects of new tobacco products. Nicotine Tob Res. 2016. - PMC - PubMed
1. Kalkhoran S, Glantz SA. Modeling the health effects of expanding e-cigarette sales in the United States and United Kingdom: a Monte Carlo analysis. JAMA Intern Med. 2015;175(10):1671–1680. doi:10.1001/jamainternmed.2015.4209. - PMC - PubMed
1. Amato MS, Boyle RG, Levy D. How to define e-cigarette prevalence? Finding clues in the use frequency distribution. Tob Control. 2016;25(e1):e24–e29. doi:10.1136/tobaccocontrol-2015-052236 - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Developing Consistent and Transparent Models of E-cigarette Use: Reply to Glantz and Soneji et al

Affiliations

Developing Consistent and Transparent Models of E-cigarette Use: Reply to Glantz and Soneji et al

Authors

Affiliations

Erratum in

Comment on

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical